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(13.85 mm2) or ESP 24218 (11.7 mm2) compared to mice receiving only saline injections
(41.3 mm2)(p<0.02 for both comparisons). Atherosclerosis in mice expressing the control
peptide (30.8 mm2) was not significantly different than in mice receiving only the saline
injection (p=ns). Conclusion. These results demonstrate an atheroprotective effect of
ESP 24218, a 22 amino acid peptide designed to mimic the activity of ApoA-I, in mice.
1064-183 Endothelial Function and Carotid Intima-Media 
Thickness in Young Healthy Subjects Among 
Endothelial Nitric Oxide Synthase Polymorphisms
Umberto Paradossi, Enrica Ciofini, Simona Storti, Nicoletta Botto, Andrea Biagini, Maria 
Giovanna Colombo, CNR Institute of Clinical Physiology, G. Pasquinucci Hospital, 
Massa, Italy
Background: To assess the role of the endothelial nitric oxide synthase (eNOS) gene
variants as risk factors for early atherosclerosis, we sought to investigate whether two
polymorphisms located in the exon 7 (Glu298→Asp) and in the promoter region (T-
786→C) of the eNOS gene were associated with functional changes in the endothelium,
and carotid intima-media thickness (IMT).
Methods: Endothelium-dependent flow-mediated brachial artery dilation (FMD), endot-
helium-independent dilation response to glyceryl trinitrate (GTN), and carotid IMT were
assessed by high resolution ultrasound in 98 healthy young non smoker subjects
(29.8±0.5 years) genotyped for the eNOS Glu298→Asp and T-786→C polymorphisms.
Results: Carotid IMT was inversely related to FMD by univariate analysis (r=-0.29,
p=0.003) and after adjustment for possible confounders in all the subjects (p=0.03). In
comparison to Glu298 homozygotes, Asp/Asp carriers displayed a significantly lower
FMD (Glu/Glu: 15.2%±1.2% vs Asp/Asp: 9.4%±1.7%, p=0.01), while FMD was unaf-
fected by the T-786→C variant (TT: 14.6%±1.1%, TC: 12.2%±0.8%, and CC:
12.0%±1.6%, p=0.18). Neither the Glu298→Asp nor the T-786→C polymorphisms influ-
enced the GTN-mediated dilation.
Moreover, Asp/Asp genotype had a significantly greater carotid IMT than Glu allele carri-
ers (Asp/Asp: 0.46±0.03 vs Glu/Glu: 0.38±0.02 and Glu/Asp: 0.36±0.01, p=0.001) and a
strong inverse correlation between FMD and carotid IMT (Glu/Glu: r=-0.15, p=0.39; Glu/
Asp: r=-0.18, p=0.23; Asp/Asp: r=-0.59, p=0.02). No difference in IMT was found across
the eNOS T-786→C genotypes (CC: 0.39±0.03, TC: 0.38±0.01, and TT: 0.38±0.02,
p=0.98).
Conclusion: The eNOS Glu298→Asp polymorphism may be related to early atherogene-
sis.
1064-184 Photodynamic Therapy Reduces Atherosclerotic Plaque 
Inflammation, Induces Plaque Stabilization and 
Promotes Plaque Reduction
Ron Waksman, Pauline McEwan, Frank Kolodgie, Travis Moore, Steve Rychnovsky, 
David Hellinga, Rufus Seaborn, Renu Virmani, Washington Hospital Center, Washington, 
DC, Miravant Medical Technologies, Inc., Santa Barbara, CA
Background: Acute coronary syndromes are associated with other sites of vulnerable
plaque located in areas of insignificant stenosis. Intravascular PhotoPointTM photody-
namic therapy (PDT) using light activation of the novel photosensitizer MV0633 is a
potential treatment for these focal segments. Previous studies have shown cell depletion
of plaque macrophages at 7 days post PDT. The aim of this study is to assess the poten-
tial of PDT to prevent re-infiltration of macrophages, stabilize plaques and promote vas-
cular remodeling at 28 days.
Methods: New Zealand white rabbits (n=28) were fed a 1% cholesterol diet followed by
bilateral iliac balloon endothelial denudation. At 5 weeks post-denudation, rabbits
received photosensitizer MV0611 (3mg/kg I.V.) followed by light delivery using a Miravant
catheter-based diode laser at 8 hours post-injection. Control animals received either drug
or light alone. After PDT, rabbits received reduced cholesterol diet (0.05%) until sacrifice
at 7 and 28 days. Arteries were sectioned every 0.5cm for a total of 16 sections/artery
and morphometrically evaluated for vessel dimensions, cell poplulation and macrophage
(Ram-11) and smooth muscle alpha actin content.
Results: At 7 days post PDT, plaque nuclei number decreased (PDT 766±231 versus
control 3012±520mm2, P<0.001) including significant loss of macrophages (PDT
.37±0.13 v's 13.9±2.3% total plaque area, P<0.001). At 28 days, plaque macrophage
area continued to be reduced with PDT treatment (PDT 0.5% v's control 8.7% total
plaque area, P<0.01) and plaque area was significantly reduced by up to 44% (PDT
0.48± 0.05 v's control 0.86±0.16 mm2) with no negative or positive arterial remodeling. At
28 days, plaque smooth muscle alpha actin content significantly increased (PDT
40.38±6.8 v's control 12.9±3.6% total plaque area) despite reduced plaque area.
Conclusions: Photopoint PDT promotes plaque reduction while simultaneously stabiliz-
ing plaques by changing plaque cellular composition from predominantly macrophages
to smooth muscle cells.
1064-185 Systemic Infections Lead to Infiltration of Macrophages 
in Adventitia of Human Atherosclerotic Coronary 
Arteries: Clue to Triggering Effect of Acute Infections on 
Acute Coronary Syndromes
Mohammad Madjid, Deborah Vela, Silvio Litovsky, Ward Casscells, Unviersity of Texas-
Houston HSC, Houston, TX, Texas Heart Institute, Houston, TX
Infections affect initiation and progression of atherosclerosis and trigger destabilization of
vulnerable plaques. One third of acute myocardial infarctions follow an upper respiratory
infection. The effect of systemic infections on human coronary artery atherosclerosis is
largely unknown.
Methods: We studied the available pathology files of St. Luke's Episcopal Hospital
between 1991 and 2002. After exclusion of patients with HIV infection, cancer, and those
taking immunosuppressive drugs, 14 patients (11M, 3F, mean age: 67 yrs) with athero-
sclerosis and an acute infection prior to death (average 2 weeks) were selected. 13 pts
(9M, 4F, mean age: 65 yrs) with atherosclerosis and without infection were selected as
controls. Slides were stained with CD68 marker for macrophages (MQ). Plaque area was
defined as the area inside the internal elastic lamina. Periadventitial fat was defined as
up to 250 µm beyond the adventitia. MQ density was the number of MQ per square mm.
Mann-Whitney U and Wilcoxon Signed Ranks tests were used.
Results: There was no significant difference in percent stenosis between cases and con-
trols (67±14 vs. 55± 25, P=0.23). MQ density in plaques showed a non-significant trend
toward higher levels in pts with systemic infection (582±774 vs. 281±321, P=0.41), how-
ever, there was a significantly higher number of MQ in adventitia of coronaries in pts with
infection compared to controls (1,577±1,872 vs. 265±185, P=0.047). MQ density in peri-
adventitial fat showed a non-significant trend toward higher levels in pts with systemic
infection (776±821 vs. 212±219, P=0.085). Of interest, while MQ density in controls was
not different between plaque and adventitia areas (281±321 vs. 265±185, P=0.85), MQ
density in patients with systemic infection was significantly higher in adventitia than in
plaque area (582±774 vs. 1,577±1,872, P= 0.028).
Conclusion: This report shows for the first time that systemic infections are associated
with a significant increase in macrophage density in adventitia of human atherosclerotic
coronary arteries. This suggests a mechanism for the triggering of AMI observed follow-
ing acute infections, and offers a new therapeutic target for preventing heart attacks.
1064-186 Magnetic Resonance Imaging Detected Relationship 
Between Atherosclerotic Plaques and Shear Stress in 
Human Descending Thoracic Aorta In Vivo
Jolanda J. Wentzel, Roberto Corti, Zahi A. Fayad, Paul Wisdom, Frank Macaluso, 
Valentin Fuster, Juan J. Badimon, Mount Sinai School of Medicine, New York, NY
Background Atherosclerotic lesions preferentially develops at low shear stress (SS) loca-
tions. Although the descending aorta is known for its particular flow patterns, no previous
studies have correlated wall thickness and shear stress in the descending thoracic
aorta.Methods and results Cross sectional images of the thoracic descending aorta of 10
asymptomatic, hypercholesteremic, untreated patients were acquired utilizing a black
blood sequence on a 1.5T clinical MRI system with a slice thickness of 5 mm and cross
sectional resolution of 0.8 mm x0.8 mm. Atherosclerotic plaques were detected and the
average wall thickness (WT) derived per quadrant. Quadrants were subdivided in four
regions dependent on the distance (DA) from the aortic arch (region I: 1.0 cm <DA<=3
cm; Region II: 3 cm<DA<5 cm , Region III: 5 cm < DA< 7 cm , Region IV: 7 cm <DA < 9
cm). Average wall thickness was maximal at region I and statistical different from the
most distal region (3.0±0.7 mm vs 2.5±0.3 mm; P<0.05). The atherosclerotic wall thick-
ening showed a helicoidally pattern from the proximal to distal segments. Phase contrast
MRI was performed in the thoracic aorta of 8 healthy volunteers, not aware of any athero-
sclerotic disease to derive a typical shear stress distribution. From the through plane
velocity profiles the average shear stress was derived in the predefined quadrants as
mean over the cardiac cycle. The atherosclerotic wall thickness showed to be inversely
related to the shear stress : WT=-1.6*SS+3.3 [mm], r2=0.29, p<0.05). Normalization of
the wall thickness (NWT) per region, emphasized that atherosclerotic plaque build up
always starts and progresses at low shear stress regions (NWT = -0.019 * SS + 1.22 ,
r2=0.59, <0.05).Conclusion Our data showing a strong correlation between wall thicken-
ing and average low shear stress locations support the role of local hemodynamics in the
development and progression of aortic atherosclerotic lesions.
1064-187 A Novel Metabolic Effect of Oxidized Low-Density 
Lipoprotein: Downregulation of Glyceraldehyde-3-
Phosphate Dehydrogenase via a CD36 Scavenger 
Receptor-Mediated Redox Pathway Involving 5-
Lipoxygenase
Sergiy Sukhanov, Koichi Ono, Yusuke Higashi, Patrick Delafontaine, Tulane University 
Health Sciences Center, New Orleans, LA
Although oxidized LDL (OxLDL) exerts multiple proatherogenic effects, its effect on key
metabolic pathways is unexplored. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) catalyzes the key glycolysis reaction and plays a major role in cell metabolism.
To examine whether OxLDL regulates GAPDH in human aortic smooth muscle cells
(HASMC), we exposed HASMC to 0-100 ug/ml CuSO4-oxidized LDL or native LDL for 0-
24 h. Western analysis and real-time PCR revealed dramatic OxLDL-specific time- and
dose-dependent decreases in GAPDH mRNA and protein levels. GAPDH/actin protein
ratios in response to 60 ug/ml of OxLDL were reduced by 65±18% (n=3) and 72±6%
(n=6) at 6h and 15h, respectively. GAPDH protein expression at 24h was virtually not
detectable and GAPDH mRNA level was reduced by 45±4% (n=3) at 15h with 60 ug/ml
OxLDL. OxLDL reduced also GAPDH specific activity (52±6%, n=3) as assessed by
measurement of NADH production. Blocking antibodies to CD36 scavenger receptor (20
ug/ml) reduced OxLDL-induced apoptosis (FACS analysis/annexin V staining) by 49%
and significantly reduced OxLDL induction of peroxides and superoxides as assessed by
CDC-H2F diacetate and hydroethidine assays, respectively. Furthermore, anti-CD36 anti-
body completely inhibited OxLDL-induced reduction in GAPDH protein (n=6). The antiox-
idant Trolox (250 uM) completely inhibited OxLDL-specific peroxide, superoxide
production (n=8) and decrease in GAPDH protein (n=3). Inhibition of cyclooxygenase-2
(NS-398, 10 uM) did not block OxLDL induction of superoxides nor reduction in GAPDH
expression whereas 5 uM NDGA, a specific 5-lipoxygenase blocker, markedly inhibited
OxLDL induction of superoxides (74±7%, n=8), peroxides (38±4%, n=8) and completely
blocked OxLDL downregulation of GAPDH. In conclusion, OxLDL downregulates
GAPDH mRNA, protein levels and enzyme activity in HASMC. This effect is mediated in
large part via the CD36 scavenger receptor and a redox signaling pathway involving 5-
lipoxygenase and contributes to the pro-apoptotic effect of OxLDL. These findings pro-
vide novel insights into metabolic effects of OxLDL on the vasculature and have major
implications for understanding mechanisms of atherogenesis.
